| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/09/1997 | WO1997016410A1 Novel inhibitors of peptide binding to mhc class ii proteins |
| 05/09/1997 | WO1997016221A2 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | WO1997016209A1 Expression of cyclin g1 in tumors |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016205A1 Antitumor agent |
| 05/09/1997 | WO1997016204A1 Continuous low-dose cytokine infusion therapy |
| 05/09/1997 | WO1997016203A1 Methods for administration of il-12 |
| 05/09/1997 | WO1997016202A1 Cytokines and their use in treatment and/or prophylaxis of breast cancer |
| 05/09/1997 | WO1997016201A1 Angiotensin iv and analogs as regulators of fibrinolysis |
| 05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
| 05/09/1997 | WO1997016189A1 Combination therapy for the treatment of diabetes and obesity |
| 05/09/1997 | WO1997016188A1 Novel inhibitors of peptide binding to mhc class ii proteins |
| 05/09/1997 | WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/09/1997 | WO1997016177A1 Method of inhibiting cathepsin k |
| 05/09/1997 | WO1997016170A1 Treatment of a coronary condition by delivery of therapeutics to the pericardial space |
| 05/09/1997 | WO1997016169A1 Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space |
| 05/09/1997 | WO1997016064A1 Methods and compositions for the reduction of xenotransplantation rejection |
| 05/09/1997 | WO1997011179A3 VARIANTS OF HUMAN RECOMBINANT INTERFERON-η (RHU-IFN-η) HAVING INCREASED HEAT-STABILITY |
| 05/09/1997 | WO1997011173A3 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 05/09/1997 | WO1997004104A3 Tumor type ii hexokinase transcription regulatory regions |
| 05/09/1997 | WO1996034885A3 Biologically active peptide fragments of ob protein |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2236274A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | CA2236171A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | CA2236111A1 Protease inhibitors |
| 05/09/1997 | CA2235223A1 Rationally designed polysaccharide lyases derived from heparinase i |
| 05/09/1997 | CA2234102A1 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | CA2233250A1 Use of protein gax for treating cancer |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | CA2209109A1 Method of inhibiting cathepsin k |
| 05/07/1997 | EP0771877A1 Gene coding for modified bone morphogenic protein receptor |
| 05/07/1997 | EP0771875A1 Porcine CNP gene and precursor protein |
| 05/07/1997 | EP0771869A1 Immunological tolerance inducing agent |
| 05/07/1997 | EP0771818A2 Biotin derivatives |
| 05/07/1997 | EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions |
| 05/07/1997 | EP0771565A2 Angiogenesis inhibitor |
| 05/07/1997 | EP0771555A2 Agent for external application with nutrient and protective properties |
| 05/07/1997 | EP0771327A1 Contraceptive vaccine |
| 05/07/1997 | EP0771325A1 Process for modifying the stability of antibodies |
| 05/07/1997 | EP0771324A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 05/07/1997 | EP0771323A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 05/07/1997 | EP0771322A1 Abundant extracellular products and methods for their production and use |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |
| 05/07/1997 | EP0771215A1 Retroviral transduction of cells using soluble complement inhibitors |
| 05/07/1997 | EP0771214A1 Treatment and prevention of helicobacter infection |
| 05/07/1997 | EP0771213A1 Haemophilus adherence and penetration proteins |
| 05/07/1997 | EP0771212A1 Contraceptive vaccine |
| 05/07/1997 | EP0771211A1 Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular diseases |
| 05/07/1997 | EP0771210A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ $g(g)1 CHAIN |
| 05/07/1997 | EP0771209A2 Novel peptides |
| 05/07/1997 | EP0771208A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 05/07/1997 | EP0771193A1 Activation of growth factors by matrix vesicles |
| 05/07/1997 | EP0771192A1 Use of anti-vegf agents in the treatment of endometriosis |
| 05/07/1997 | EP0771189A1 Inhalation composition |
| 05/07/1997 | EP0771147A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/07/1997 | EP0771146A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase |
| 05/07/1997 | EP0703778B1 Methods and apparatus for making liposomes |
| 05/07/1997 | EP0681578B1 Antiviral naphthoquinone compounds, compositions and uses thereof |
| 05/07/1997 | EP0667780A4 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents. |
| 05/07/1997 | EP0663835B1 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy |
| 05/07/1997 | EP0661993B1 Protection against liver damage by hgf |
| 05/07/1997 | EP0651764B1 Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor |
| 05/07/1997 | EP0621870B1 A human kunitz-type protease inhibitor variant |
| 05/07/1997 | EP0602050B1 Method of stimulating immune response |
| 05/07/1997 | EP0570583B1 Hair modifier and hair care product, both containing antikeratinous antibody, and production of antikeratinous antibody |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0532716B1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 05/07/1997 | EP0464155B1 Endothelial cell growth factor, isolation and expression |
| 05/07/1997 | DE19541283A1 Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New amino acid derivatives, to processes for their preparation containing these compounds and pharmaceutical compositions |
| 05/07/1997 | DE19540902A1 Protein mit Anti-Tumorwirkung Protein with anti-tumor activity |
| 05/07/1997 | CN1149319A Angiostatin and method of use for inhibition of Angiogenesis |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149292A Pyrimidinyl derivatives as interleukin inhibitors |
| 05/07/1997 | CN1149258A Inhibin compositions and methods of use thereof |
| 05/07/1997 | CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/07/1997 | CN1148985A Injection for emetic action anc clearing stomach |
| 05/07/1997 | CN1148984A Process for preparing pharmaceutical formulation containing insulin analog |
| 05/07/1997 | CN1034805C Preparation of amino acid derivatives |
| 05/06/1997 | USRE35500 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/06/1997 | USH1649 HIV protease inhibitor combinations |
| 05/06/1997 | US5627283 Antithrombin compounds |
| 05/06/1997 | US5627278 Process for preparing compounds containing a fused bicyclic ring |
| 05/06/1997 | US5627274 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 05/06/1997 | US5627268 Hemoglobin comprising globin fusion proteins |
| 05/06/1997 | US5627267 Cytokine designated elk ligand |
| 05/06/1997 | US5627266 Neutralizing toxic effect or bioactivity of endotoxin which is isolated from horseshoe crab; immobilized on a solid phase support of chromatographic resin membrane |
| 05/06/1997 | US5627265 Receptor for cell-binding domain of thrombospondins |
| 05/06/1997 | US5627264 Chimeric complement inhibitor proteins |
| 05/06/1997 | US5627263 Wound healing and antitumor agents |
| 05/06/1997 | US5627262 Method and composition for the treatment of septic shock |
| 05/06/1997 | US5627210 Tripeptides for antiinflammatory agents and antitumor agents |
| 05/06/1997 | US5627202 Inhibitors of farnesyl-protein transferase |
| 05/06/1997 | US5627158 Antisense oligonucleotides of human regulatory subunit RI-.sub.α of camp dependent protein kinases for the treatment of cancer |
| 05/06/1997 | US5627156 Polypeptide agonists for human interleukin-8 |
| 05/06/1997 | US5627155 Controlling diseases with proteins such as allergies, psoriasis, tissue rejection and autoimmune diseases |
| 05/06/1997 | US5627154 Calcium channel blocking polypeptides from Heteropoda venatoria |
| 05/06/1997 | US5627153 Anti-fungal methods and materials |
| 05/06/1997 | US5627152 Method for increasing bodyweight |
| 05/06/1997 | US5627073 Hybridomas producing antibodies to cardiac hypertrophy factor |